Advanced search
Publication Cover
OncoImmunology Volume 7, 2018 - Issue 3
Submit an article Journal homepage
2,575
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade

Koji NagaokaDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan
,
Akihiro HosoiDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan
,
Tamaki IinoDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan;Medinet Co. Ltd., Kohoku-Ku, Yokohama, Japan
,
Yasuyuki MorishitaDepartment of Molecular Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-Ku, Tokyo, Japan
,
Hirokazu MatsushitaDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, Japan
&
Kazuhiro KakimiDepartment of Immunotherapeutics, The University of Tokyo Hospital, Bunkyo-Ku, Tokyo, JapanCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-2631-3040
ORCID Icon
Article: e1395124 | Received 22 Aug 2017, Accepted 16 Oct 2017, Published online: 20 Nov 2017

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Isaure Vanmeerbeek, Jenny Sprooten, Dirk De Ruysscher, Sabine Tejpar, Peter Vandenberghe, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2020) Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology. OncoImmunology 9:1.
Read now
Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Laurence Zitvogel, Guido Kroemer, Lorenzo Galluzzi & Abhishek D. Garg. (2019) Trial watch: dendritic cell vaccination for cancer immunotherapy. OncoImmunology 8:11.
Read now
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, Jonathan Pol, Jitka Fucikova, Radek Spisek, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2018) Trial watch: Peptide-based vaccines in anticancer therapy. OncoImmunology 7:12.
Read now

Articles from other publishers (16)

Si-Wei Zhang, Han Wang, Xiao-Hong Ding, Yu-Ling Xiao, Zhi-Ming Shao, Chao You, Ya-Jia Gu & Yi-Zhou Jiang. (2023) Bidirectional crosstalk between therapeutic cancer vaccines and the tumor microenvironment: Beyond tumor antigens. Fundamental Research 3:6, pages 1005-1024.
Crossref
Sajad Najafi & Keywan Mortezaee. (2023) Advances in dendritic cell vaccination therapy of cancer. Biomedicine & Pharmacotherapy 164, pages 114954.
Crossref
Rachel Weil & David Loeb. (2023) Breaking down the tumor immune infiltration within pediatric sarcomas. Frontiers in Endocrinology 14.
Crossref
Eleonora Sosa Cuevas, Philippe Saas & Caroline Aspord. (2023) Dendritic Cell Subsets in Melanoma: Pathophysiology, Clinical Prognosis and Therapeutic Exploitation. Cancers 15:8, pages 2206.
Crossref
Hao Chang, Xueyu Wen, Zhiming Li, Zhixin Ling, Yanting Zheng & Chenjie Xu. (2022) Co‐delivery of dendritic cell vaccine and anti‐PD ‐1 antibody with cryomicroneedles for combinational immunotherapy . Bioengineering & Translational Medicine.
Crossref
Farid Ghorbaninezhad, Zahra Asadzadeh, Javad Masoumi, Ahad Mokhtarzadeh, Tohid Kazemi, Leili Aghebati-Maleki, Siamak Sandoghchian Shotorbani, Mahdi Abdoli Shadbad, Amir Baghbanzadeh, Nima Hemmat, Mohammad Bakhshivand & Behzad Baradaran. (2022) Dendritic cell-based cancer immunotherapy in the era of immune checkpoint inhibitors: From bench to bedside. Life Sciences 297, pages 120466.
Crossref
Yubao Lu, Jiahe Zhang, Yutong Chen, Yuchen Kang, Zhipeng Liao, Yuanqi He & Cangyu Zhang. (2022) Novel Immunotherapies for Osteosarcoma. Frontiers in Oncology 12.
Crossref
Koji Nagaoka, Changbo Sun, Yukari Kobayashi, Takayuki Kanaseki, Serina Tokita, Toshihiro Komatsu, Kazuhiro Maejima, Junichiro Futami, Sachiyo Nomura, Keiko Udaka, Hidewaki Nakagawa, Toshihiko Torigoe & Kazuhiro Kakimi. (2021) Identification of Neoantigens in Two Murine Gastric Cancer Cell Lines Leading to the Neoantigen-Based Immunotherapy. Cancers 14:1, pages 106.
Crossref
João Calmeiro, Mylène A. Carrascal, Adriana Ramos Tavares, Daniel Alexandre Ferreira, Célia Gomes, Maria Teresa Cruz, Amílcar Falcão & Bruno Miguel Neves. (2021) Pharmacological combination of nivolumab with dendritic cell vaccines in cancer immunotherapy: An overview. Pharmacological Research 164, pages 105309.
Crossref
Mona Kamal Saadeldin, Amal Kamal Abdel-Aziz & Ahmed Abdellatif. (2021) Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. Medical Hypotheses 146, pages 110365.
Crossref
Kristian M. Hargadon. (2020) Tumor microenvironmental influences on dendritic cell and T cell function: A focus on clinically relevant immunologic and metabolic checkpoints. Clinical and Translational Medicine 10:1, pages 374-411.
Crossref
Chiao-Fang Teng, Ting Wang, Tzu-Hua Wu, Jia-Hui Lin, Fu-Ying Shih, Woei-Cherng Shyu & Long-Bin Jeng. (2020) Combination therapy with dendritic cell vaccine and programmed death ligand 1 immune checkpoint inhibitor for hepatocellular carcinoma in an orthotopic mouse model. Therapeutic Advances in Medical Oncology 12, pages 175883592092203.
Crossref
Zenan Wang, Zhan Wang, Binghao Li, Shengdong Wang, Tao Chen & Zhaoming Ye. (2019) Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma. Frontiers in Immunology 10.
Crossref
Gheath Alatrash, Alyssa K. Crain & Jeffrey J. Molldrem. 2019. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation. Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation 107 125 .
Mandy van Gulijk, Floris Dammeijer, Joachim G. J. V. Aerts & Heleen Vroman. (2018) Combination Strategies to Optimize Efficacy of Dendritic Cell-Based Immunotherapy. Frontiers in Immunology 9.
Crossref
Alessandra Lopes, Kevin Vanvarenberg, Špela Kos, Sophie Lucas, Didier Colau, Benoît Van den Eynde, Véronique Préat & Gaëlle Vandermeulen. (2018) Combination of immune checkpoint blockade with DNA cancer vaccine induces potent antitumor immunity against P815 mastocytoma. Scientific Reports 8:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.